This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
See You Next Year! 26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Hwanho Choi, M.D., Ph.D.
CEO and Founder at Quantum Intelligence Corporation


Hwanho Choi is the founder and C.E.O of Quantum Intelligence corp.,
he has developed drug development platform (QUEST) to predict the chemical and drug properties of peptides using Quantum mechanical calculation and Artificial intelligence.
Prior to working at Quantum Intelligence, he earned a Ph.D., in Chemistry from University of Oxford, a B.S., in Physics from Seoul National University.
His academic research interests include protein-ligand interactions, solvation process and hydrophobicity.

Agenda Sessions

  • Macrocyclic Peptide Drug Development by Combining the Strengths of all Small Fragments, mRNA Display and AI Technologies